ENO1 and neoplasm: This study presents the tumor-suppressive action of AMPK-inhibited PBMC/lymphocyte-derived CM and evaluates the role of ENO1/MSN-Mtdh regulatory axis as well as PABPC1 in suppressing the progression of breast cancer (Fig. 8E).